Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease

Robert Tulloh, Michael Marsh, Michael Blackburn, Frank Casey, Warren Lenney, Peter Weller, Barry R. Keeton

Research output: Contribution to journal › Article › peer-review

38 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology